Search
Filter Results
Displaying 201–210 of 830 for “retinal diseases”
-
X-linked retinoschisis (XLRS) is an inherited retinal diseasing causing vision loss due to splitting of the layers of the retina.
-
Apr 22, 2020
The inaugural credit-based event will include education on inherited retinal diseases, physician resources, and current clinical trials.
-
Jul 16, 2018
Dr. Kelley brings more than 25 years of experience in developing, identifying, and advancing life science technologies to this leadership role at FFB
-
Sep 6, 2016
Researchers Identify Canine Model of LCA (NPHP5) — Pursue Gene Therapy
The investigators found that in canines, the retinal degeneration is remarkably similar to that in humans with NPHP5 mutations.
-
Oct 28, 2021
RD Fund Announces Fundraising Efforts Underway for RD Fund 2
Patient-centric venture philanthropy model continues to invest in companies developing therapies for individuals affected by retinal degenerative diseases.
-
Jun 29, 2017
Researchers Find Mutation as Frequent Cause of RP in American Hispanics
The discovery can help genetic experts diagnose more patients with adRP, and it gives researchers a target for developing potential therapies.
-
Dec 13, 2021
Ocugen to Launch Clinical Trial for Cross-Cutting RP Gene Therapy
The clinical trial is for RHO and NR2E3 mutations, but the retinal gene therapy has the potential to benefit people with a variety of other mutated genes
-
Apr 13, 2016
Foundation Fighting Blindness Announces Leadership Succession Plan After 45 Year Legacy
David Brint has been elected Chairman, effective July 1, 2016. Brint succeeds co-founder and current Chairman, Gordon Gund, who will remain a member of the Board of Directors and will continue to be actively involved in the Foundation’s Research Oversight Committee
-
May 2, 2023
Foundation Fighting Blindness and Athletes for Hope Announce Strategic Partnership
This partnership will drive awareness for blinding diseases throughout the athletic community.
-
Feb 6, 2024
Foundation Fighting Blindness Launches GYROS, a Natural History Study for People with Gyrate Atrophy
Gyrate atrophy is an inherited retinal disease—causing progressive vision loss. GYROS results will help researchers design clinical trials for an emerging gyrate atrophy gene therapy.